Financial News

Week in Review: $1.5 Billion Total in Week's China Deals

Deals and Financings   Everest Medicines of Shanghai completed a $451 million IPO in Hong Kong to develop eight assets in-licensed for China development; Genor Biopharma of Shanghai raised $371 million in its Hong Kong IPO and rose 22%, giving the company a market capitalization of $1.8 billion; 10x Genomics will pay $350 million to acquire Decheng-backed ReadCoor, a Boston developer of spatial-onomics sequencing devices; Hinova, a Chengdu novel drug biopharma, closed a $147 million Series C round for nine assets including treatments for prostate cancer and gout; Corvus Pharma formed a China subsidiary, Angel Pharma, with a $106 million valuation to develop its assets in China ; Creative Biosciences, a Guangzhou oncology testing company, raised $90 million for diagnostic products, including a stool-based test for colon cancer; Guangzhou Link Health and Shenzhen Pregene announced a $65 million deal to acquire China/Asia rights to a cell therapy for bone fractures; Covid-19 Pandemic Junshi Bio of Shanghai and Lilly released positive interim data from a Phase II trial of their paired COVID-19 antibody treatment; Fosun Pharma was granted US FDA approval to begin clinical tests of its investigational COVID-19 antibody treatment; Trials and Approvals   Harbour BioMed, a China-US biopharma, began a China Phase II trial of a treatment for myasthenia gravis and adult immune thrombocytopenia; Zai Lab of Shanghai dosed the first patient in a China Phase III trial of a PD-1 antibody in first-line NSCLC; Shanghai 's CARsgen Therapeutics was granted orphan drug designation in the US for its anti-claudin18.2 CAR-T candidate in patients with gastric adenocarcinoma. Stock Symbols: (HK:1952) (HK: 6998) (NSDQ: TXG) (NSDQ: CRVS) (HK: 1877; SHA: 688180) (NYSE: LLY) (SHA: 600196; HK: 02196) (NSDQ: ZLAB; HK: 9688) Share this with colleagues: // //
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info